Drug General Information |
Drug ID |
D09UQM
|
Former ID |
DNC006812
|
Drug Name |
1-(3,4-dichlorophenyl)-3-hydroxyurea
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C7H6Cl2N2O2
|
Canonical SMILES |
C1=CC(=C(C=C1NC(=O)NO)Cl)Cl
|
InChI |
1S/C7H6Cl2N2O2/c8-5-2-1-4(3-6(5)9)10-7(12)11-13/h1-3,13H,(H2,10,11,12)
|
InChIKey |
VKYZMAVGJARVPE-UHFFFAOYSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Carbonic anhydrase |
Target Info |
Inhibitor |
[1]
|
Carbonic anhydrase IV |
Target Info |
Inhibitor |
[1]
|
Carbonic anhydrase IX |
Target Info |
Inhibitor |
[1]
|
Carbonic anhydrase II |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
Nitrogen metabolism
|
Proximal tubule bicarbonate reclamationhsa00910:Nitrogen metabolismhsa00910:Nitrogen metabolism
|
Proximal tubule bicarbonate reclamation
|
Collecting duct acid secretion
|
Gastric acid secretion
|
Pancreatic secretion
|
Bile secretion
|
NetPath Pathway
|
IL4 Signaling Pathway
|
EGFR1 Signaling Pathway
|
Pathway Interaction Database
|
HIF-1-alpha transcription factor network
|
Reactome
|
Erythrocytes take up carbon dioxide and release oxygen
|
Erythrocytes take up oxygen and release carbon dioxide
|
Reversible hydration of carbon dioxideR-HSA-1234158:Regulation of gene expression by Hypoxia-inducible Factor
|
Reversible hydration of carbon dioxideR-HSA-1237044:Erythrocytes take up carbon dioxide and release oxygen
|
Reversible hydration of carbon dioxide
|
WikiPathways
|
Reversible Hydration of Carbon Dioxide
|
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
|
Uptake of Oxygen and Release of Carbon Dioxide by ErythrocytesWP2877:Vitamin D Receptor Pathway
|
Regulation of Hypoxia-inducible Factor (HIF) by OxygenWP2770:Reversible Hydration of Carbon Dioxide
|
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
|
References |
REF 1 | Bioorg Med Chem Lett. 2006 Aug 15;16(16):4316-20. Epub 2006 Jun 12.N-hydroxyurea--a versatile zinc binding function in the design of metalloenzyme inhibitors. |